This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The top life science companies work extensively with a network of external market and competitiveintelligence (M/CI) vendors. M/CI plays a significant role in the decision making process of leading life science companies across all areas of the industry - including the pharmaceutical, biotechnology, and medical device sectors.
In partnership with Forrester Research , Cipher conducted a study in March 2021 exploring how life science companies and third-party market and competitiveintelligence (M/CI) vendors can best work together.
In partnership with Forrester Research , Cipher conducted a study in March 2021 exploring how life science companies and third-party market and competitiveintelligence (M/CI) vendors can best work together.
In partnership with Forrester Research , Cipher conducted a study in March 2021 exploring how life science companies and third-party market and competitiveintelligence (M/CI) vendors can best work together.
In partnership with Forrester Research , Cipher conducted a study in March 2021 exploring how life science companies and third-party market and competitiveintelligence (M/CI) vendors can best work together.
Ryan Tohill is currently an associate director of global competitiveintelligence for dermatology and rheumatology at The Janssen Pharmaceutical Companies of Johnson & Johnson, based in Horsham, Pennsylvania. Tohill is not new to the world of medicine and pharmaceutical sciences. ArchIntel™ -.
Are you interested in a career in competitiveintelligence? The industry is constantly growing as organisations recognise the value of mapping the competitive landscape, and quantifying the threats and opportunities presented by rivals. Aqute Intelligence is always looking for new analysts to join our global team.
The short answer is that yes, competitiveintelligence is an ethical business activity. The longer answer is that intelligence gathering can stray into unethical territory, and it’s important for competitiveintelligence firms to understand the risks and have policies for staying on the right side of the ethical (and legal) divide.
IQVIA, a provider of advanced analytics, technology solutions and clinical research services for the life sciences industry, is looking for an associate consultant on competitiveintelligence. The post IQVIA Seeking Pennsylvania-Based Associate CompetitiveIntelligence Consultant appeared first on ArchIntel™.
pharmaceutical industry in 2021 and beyond. The race to create new products against COVID-19 amid the emergence of new mutations is expected to eclipse every other effort in health care and pharmaceuticals this year. This fierce competition is predicted to propel the U.S. ArchIntel™ -. These are some of the U.S.
A director of competitiveintelligence role is open at Moderna , one of the pharmaceutical companies that has developed a vaccine for COVID-19. The director will also assess the reliability of competitiveintelligence research findings to maintain high standards of accuracy, relevance and quality, Moderna noted.
Understanding your competitors' strategies in today’s highly competitivepharmaceutical industry can give your brand a crucial edge. With the pharmaceutical and healthcare advertising market booming in the United States, leveraging competitiveintelligence has never been more essential.
“The global pharmaceutical manufacturing market is expected to garner growth at a noteworthy CAGR of 12.8% Bristol Myers Squibb , a biopharmaceutical company, is looking to hire an associate director of competitiveintelligence focused on hematology and oncology. ArchIntel™ -. from 2021 to 2030.”
“The global pharmaceutical manufacturing market is expected to garner growth at a noteworthy CAGR of 12.8% LEO Pharma has put the word out that it is on the hunt for its next associate director for market research and competitiveintelligence for its operations in the United States. ArchIntel™ -. from 2021 to 2030.”
Recruitment company Harnham has posted a job advertisement for a senior manager of competitiveintelligence who will be based in Boston, Massachusetts. The role will provide competitiveintelligence and strategic insights across organizations within a company that focuses on biotechnology. ArchIntel™ -.
“Global pharmaceutical manufacturing industry will reach $673.6 Competitiveintelligence can help pharmaceutical companies secure drug approval from the Food and Drug Administration, according to Cipher President Peter Grimm. ArchIntel™ -. billion by 2027, growing by 12.5%
AbbVie, a science and health care company , has announced an opening for a full-time associate director of competitiveintelligence for immunology. The role is responsible for providing detailed and actionable intelligence about competitive forces in the current and future market, AbbVie said. ArchIntel™ -.
Richard Petronzio has been working for Bayer Pharmaceuticals for more than six years and currently serves as senior director of business insights at the German company. Before joining Bayer Pharmaceuticals, he was with Platform Advisors, a division of The CDM Group, according to his LinkedIn profile. ArchIntel™ -.
Volkan Gunduz is an associate director of competitiveintelligence for global oncology at Sanofi Genzyme, based in Cambridge, Massachusetts. However, he is not new to the pharmaceutical and health care industry. ArchIntel™ -. He later earned his doctorate in genetics from the Tufts University School of Medicine.
In today’s highly competitive and rapidly advancing pharmaceutical industry, a well-oiled competitiveintelligence process is essential in order to drive business success.
The global pharmaceutical industry in itself is highly competitive, driven by a constant need to innovate and discover new drugs. Producing and manufacturing drugs and medical devices is an expensive business to be a part of.
health care sector is seen to experience an unprecedented level of competition. Through all this, competitiveintelligence professionals will surely be pushed hard to generate much-needed insights. Executive Profile: Arnold DuBell, Associate Competitive and Strategic Intelligence Director at Novartis.
Join our webinar on June 27th at 10-11am ET In response to the economic downturn, supply chain disruption, and geopolitical tensions, companies are increasingly relying on competitiveintelligence and research.
In today’s highly competitive and rapidly advancing pharmaceutical industry, a well-oiled competitiveintelligence process is essential in order to drive business success.
This website allows users to confirm whether a health care product is legitimate or not by scouring its database of dietary supplements, designer drugs, pharmaceuticals and other health care products and websites. LegitScript.com rounds out the list of OSINT tools recommended by the Hetherington Group.
“The global pharmaceuticals market size is expected to gain momentum by reaching USD 2,151.1 PharmaEssentia has posted a job opening on LinkedIn for a full-time business intelligence and analytics director. The role also has competitiveintelligence functions. ArchIntel™ -. between 2020 and 2027.”
The senior manager will serve as a strategic thought partner and expert in analytical and market research to help inform life-cycle planning, forecasting and senior management decisions that require primary market research and competitiveintelligence.
Pharmaceutical company AstraZeneca capitalized on the potential of its workforce to develop a COVID-19 vaccine. The majority of the leaders surveyed in the Deloitte study said that employees’ ability to adapt, reskill and assume new roles are critical in thriving amid constant disruption.
In the ever-evolving world of pharmaceuticals, where innovation and breakthroughs occur at an astounding pace, businesses find themselves in a constant race for relevance and success. Staying ahead of the curve is no longer just a competitive edge; it's a necessity.
Anindita Niyogi is the director of global customer analytics and insights at Pfizer , one of the pharmaceutical companies that has developed a vaccine for the novel coronavirus disease. Before joining Pfizer, she spent seven years at AstraZeneca Pharmaceuticals , which has also developed a COVID-19 vaccine. ArchIntel™ -.
In light of the opportunities and challenges faced by the A&D industry this year, knowing how competitors intend to adapt is strategically important, making the role of competitiveintelligence executives critical. Stefanie Kowitt is the head of Lockheed Martin’s capture excellence and competitiveintelligence team.
The COVID-19 pandemic has ushered in a seismic shift in the pharmaceutical industry. How Pharmaceutical Market Research Is Changing Historically, market research methods in the pharmaceutical industry involved relying on historical datasets and manually searching for information from incomplete and disparate sources.
Nowhere is competitive benchmarking more important than in the global pharmaceutical industry, where the process for developing and releasing a new drug is complex, high-risk, and requires significant effort and resources. Bonus: Download our guide on competitive benchmarking tactics for pharmaceutical companies.
Nowhere is competitive benchmarking more important than in the global pharmaceutical industry, where the process for developing and releasing a new drug is complex, high-risk, and requires significant effort and resources. Bonus: Download our guide on competitive benchmarking tactics for pharmaceutical companies.
We’ll analyze patient decision journey clues that OTC brands and pharmaceutical companies need to tune into, as well as how to spot them here. No matter what the cause, it’s critical for OTC brands and pharmaceutical companies to locate this intel to better inform their efforts. Likewise, if they fail, you’ll know what not to do.
Several leading pharmaceutical companies working with flawed assumptions were operating with serious blind-spots. to connect with a reputed market and competitiveintelligence company and leverage their technology and robust processes to minimise or eliminate these risks. How often is win-loss analysis deployed?
Chemonics has awarded its largest subawards to companies providing pharmaceutical and other health products on this IDIQ. . We recognize this is a cross over of health and supply chain management.
Interestingly, the pharmaceutical and medicine manufacturing subsector has seen the highest job growth numbers recently, even overtaking the aerospace products and parts subsector. In such an environment, competitiveintelligence professionals must work extra hard to deliver desperately-needed insights.
Contify, an AI-enabled market and competitiveintelligence solutions provider, announced today that it has successfully deployed its platform to generate customized daily competitiveintelligence reports for a leading pharma company focused on the development of novel drugs to treat rare diseases. About Contify.
To survive in today’s fast-moving and always-evolving market landscape, every business needs competitiveintelligence (CI)—comprehensive knowledge about your competitors and how your company stacks up. CI allows you to track competitor behavior and glean the insights you need to create competitive advantages.
The business development manager, who will be based in Cambridge, Massachusetts, will be tasked with continuing to build N-SIDE Suite product momentum, collecting competitiveintelligence and increasing N-SIDE market share by collaborating with the company’s marketing team, product team and account managers.
Applying competitiveintelligence, we can identify the risks and opportunities our clients face, to help them objectively understand their market and take appropriate action to thwart those risks and capture those new opportunities. How Fuld + Company works with our clients.
Our report details this shift across various sectors, including Banking and Finance, Consumer Products, Food and Beverage, Healthcare and Pharmaceutical, Media and Entertainment, Retail, Technology, Transportation, and Travel and Hospitality. You can see how other use cases, such as crisis management , VOC, and more, ranked in our report.
For example, our company Aqute could be in competitiveintelligence , or market research, or consulting. If we decide we are in competitiveintelligence, we could be in competitiveintelligence software or competitiveintelligence services.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content